Generation of an induced pluripotent stem cell line (TRNDi012-B) from Fibrodysplasia Ossificans Progressiva (FOP) patient carrying a heterozygous mutation c. 617G > A in the ACVR1 gene

Stem Cell Res. 2021 Jul:54:102424. doi: 10.1016/j.scr.2021.102424. Epub 2021 Jun 7.

Abstract

Fibrodysplasia ossificans progressiva (FOP) is a rare autosomal dominant disorder of progressive ossification of skeletal muscle, fascia, tendons, and ligaments. Most FOP cases are caused by a heterozygous c. 617G > A mutation in the ACVR1 gene which encodes a gain-of-function of bone morphogenetic protein type I receptor. A human induced pluripotent stem cell (iPSC) line was generated from the dermal skin fibroblasts of a FOP patient who carries the c. 617G > A mutation in the ACVR1 gene. This iPSC line provides an attractive resource for FOP disease modeling.

Publication types

  • Research Support, N.I.H., Intramural

MeSH terms

  • Activin Receptors, Type I / genetics
  • Heterozygote
  • Humans
  • Induced Pluripotent Stem Cells*
  • Mutation
  • Myositis Ossificans* / genetics

Substances

  • ACVR1 protein, human
  • Activin Receptors, Type I